Literature DB >> 26278019

The effect of EUSOMA certification on quality of breast cancer care.

P A van Dam1, M Tomatis2, L Marotti3, J Heil4, R Wilson5, M Rosselli Del Turco3, C Mayr6, A Costa7, M Danei8, A Denk9, G Emons10, K Friedrichs11, N Harbeck12, M Kiechle13, U Koheler14, S Kuemmel15, N Maass16, C Marth17, A Prové18, R Kimmig19, C Rageth20, L Regolo21, L Salehi22, D Sarlos23, C Singer24, C Sohn4, G Staelens25, C Tinterri26, A Ponti2.   

Abstract

AIM OF THE STUDY: The European Society of Breast Cancer Specialists (EUSOMA) has fostered a voluntary certification process for breast units to establish minimum standards and ensure specialist multidisciplinary care. In the present study we assess the impact of EUSOMA certification for all breast units for which sufficient information was available before and after certification.
MATERIALS AND METHODS: For 22 EUSOMA certified breast units data of 30,444 patients could be extracted from the EUSOMA database on the evolution of QI's before and after certification.
RESULTS: On the average of all units, the minimum standard of care was achieved for 12/13 QI's before and after EUSOMA certification (not met for DCIS receiving just one operation). There was a significant improvement of 5 QI's after certification. The proportion of patients with invasive cancer undergoing an axillary clearance containing >9 lymph nodes (91.5% vs 89.4%, p 0.003) and patients with invasive cancer having just 1 operation (83.1% vs 80.4%, p < 0.001) dropped, but remained above the minimum standard. The targeted standard of breast care was reached for the same 4/13 QI's before and after EUSOMA certification.
CONCLUSION: Although the absolute effect of EUSOMA certification was modest it further increases standards of care and should be regarded as part of a process aiming for excellence. Dedicated units already provide a high level of care before certification, but continuous monitoring and audit remains of paramount importance as complete adherence to guidelines is difficult to achieve.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Audit; Benchmarking; Breast cancer; Chemotherapy; EUSOMA; Quality control; Radiotherapy

Mesh:

Year:  2015        PMID: 26278019     DOI: 10.1016/j.ejso.2015.06.006

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

Review 1.  Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis.

Authors:  Giovanni Mauri; Luca Maria Sconfienza; Lorenzo Carlo Pescatori; Maria Paola Fedeli; Marco Alì; Giovanni Di Leo; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2017-01-03       Impact factor: 5.315

2.  Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters.

Authors:  Jeffrey Landercasper; Oluwadamilola M Fayanju; Lisa Bailey; Tiffany S Berry; Andrew J Borgert; Robert Buras; Steven L Chen; Amy C Degnim; Joshua Froman; Jennifer Gass; Caprice Greenberg; Starr Koslow Mautner; Helen Krontiras; Luis D Ramirez; Michelle Sowden; Barbara Wexelman; Lee Wilke; Roshni Rao
Journal:  Ann Surg Oncol       Date:  2017-11-22       Impact factor: 5.344

3.  Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators.

Authors:  Delphine Héquet; Cyrille Huchon; Sandrine Baffert; Séverine Alran; Fabien Reyal; Thuy Nguyen; Alix Combes; Caroline Trichot; Karine Alves; Hélène Berseneff; Roman Rouzier
Journal:  Br J Cancer       Date:  2017-04-25       Impact factor: 7.640

4.  Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey.

Authors:  Annemie Luyckx; Leen Wyckmans; Anne-Sophie Bonte; Xuan Bich Trinh; Peter A van Dam
Journal:  BMC Womens Health       Date:  2020-07-23       Impact factor: 2.809

5.  Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.

Authors:  Anne Cowppli-Bony; Brigitte Trétarre; Emilie Marrer; Gautier Defossez; Laetitia Daubisse-Marliac; Gaelle Coureau; Pamela Minicozzi; Anne-Sophie Woronoff; Patricia Delafosse; Florence Molinié
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

6.  Effects of Out-of-Hospital Continuous Nursing on Postoperative Breast Cancer Patients by Medical Big Data.

Authors:  Peijuan He; Bing Zhang; Songna Shen
Journal:  J Healthc Eng       Date:  2022-01-06       Impact factor: 2.682

7.  Evaluation of Quality Indicators of Breast Cancer Management at a Tertiary Cancer Center in Nepal.

Authors:  Shweta Baral; Sudhir Raj Silwal; Utsav Man Shrestha; Deep Lamichhane
Journal:  JCO Glob Oncol       Date:  2022-03

8.  Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study.

Authors:  Antonella Ciabattoni; Fabiana Gregucci; Giuseppe D'Ermo; Alessandro Dolfi; Francesca Cucciarelli; Isabella Palumbo; Simona Borghesi; Alessandro Gava; Giovanna Maria Cesaro; Antonella Baldissera; Daniela Giammarino; Antonino Daidone; Francesca Maurizi; Marcello Mignogna; Lidia Mazzuoli; Vincenzo Ravo; Sara Falivene; Sara Pedretti; Edy Ippolito; Rosaria Barbarino; Daniela di Cristino; Alba Fiorentino; Cynthia Aristei; Sara Ramella; Rolando Maria D'Angelillo; Icro Meattini; Cinzia Iotti; Vittorio Donato; Silvia Chiara Formenti
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

9.  Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study.

Authors:  L van Walle; K Punie; E Van Eycken; E de Azambuja; H Wildiers; F P Duhoux; P Vuylsteke; A Barbeaux; N Van Damme; D Verhoeven
Journal:  ESMO Open       Date:  2021-07-14

10.  De-Escalating Breast Cancer Surgery: Should We Apply Quality Indicators from Other Jurisdictions in Canada?

Authors:  Hannah Kapur; Leo Chen; Rebecca Warburton; Jin-Si Pao; Carol Dingee; Urve Kuusk; Amy Bazzarelli; Elaine McKevitt
Journal:  Curr Oncol       Date:  2021-12-29       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.